In Caucasian hypertensives and diabetics, increased RBC sodium-lithium countertransporter activity (SLC) is a marker for end-organ complications of vascular disease. A subgroup of African Americans with high V max for SLC show strong correlations with dyslipidaemia, insulin resistance, microalbuminuria and higher blood pressure. The purpose of our study was to determine if V max in premenopausal African American women correlates with left ventricular mass (LVM) before the onset of clinically diagnosed hypertension. Non-diabetic African American women (n ‫؍‬ 35, mean age 31 years) were evaluated for cardiovascular disease risk factors, including anthropometric and blood pressure measurements, oral glucose tolerance test (OGTT), and euglycaemic hyperinsulinaemic clamp for insulin sensitivity. Fasting blood specimens were assayed for SLC activity (V max ) and lipids. Cardiac structure was determined by 2-D echocardiography. LVM was calculated by the cube
Introduction
Increased activity of the red blood cell (RBC) sodium-lithium countertransporter (SLC) is a marker for end-organ complications in Caucasian hypertensives and diabetics. [1] [2] [3] Although the V max for SLC is lower in African Americans compared to Caucasians, 4 a subgroup of African Americans with high V max for SLC display higher blood pressure, blood lipid alterations, insulin resistance and microalbuminuria. [5] [6] While a strong relationship of elevated V max for SLC with cardiac and renal abnormalities has been reported in Caucasians with established hypertension and diabetics, 7 little is known about the capacity of V max for SLC to predict end-organ injury in a high-risk group.
Systolic blood pressure is a correlate of left ventricular mass (LVM) in women with defined hypertension. 8, 9 Left ventricular hypertrophy (LVH) is an independent cardiac risk factor. 10 The purpose of this study was to determine if V max for SLC in premenopausal African American women is related to cardiac structure prior to clinically diagnosed hypertension or diabetes. We also examined relationships of V max for SLC with other metabolic parameters, including insulin resistance and lipids.
Materials and methods

Study population
The study was conducted on 80 non-diabetic African American women. For this study, African American was defined as self report of African ethnic group. Each case reported that she and both parents were born in the United States and all were of African origin. Each participant was drawn from a cohort that has been under study in investigations of blood pressure and cardiovascular risk factors. Participants enrolled in this study included normotensives (blood pressure Ͻ135 mm Hg systolic and Ͻ85 mm Hg diastolic) and borderline hypertensives (blood pressure у135 and Ͻ150 mm Hg systolic or у85 and Ͻ96 mm Hg diastolic), based on repeated measurements of blood pressure. Exclusion criteria included diabetes, history of irregular menses, use of antihypertensive medications and hormonal contraceptive use. All studies were conducted during the follicular phase of the menstrual cycle.
Procedures
Enrolment assessment consisted of physical examination, anthropometric measurements and blood pressure determination. Casual systolic (first phase) and diastolic (fifth phase) blood pressure measurement was obtained by auscultation with a mercury column sphygmomanometer in the seated position following a 5-min rest period. The average of two determinations was used as the blood pressure at the time of metabolic evaluation. From the anthropometric measurements, body mass index (BMI, in kg/m 2 ), central obesity, percent body fat 11 and fatfree mass 12 were calculated. Following the enrolment assessment, each subject returned to the clinical research unit for an oral glucose tolerance test (OGTT), which was scheduled in the morning following an overnight fast. Fasting blood specimens were obtained for glucose, insulin, lipids and sodium-lithium countertransport assay. The euglycaemic hyperinsulinaemic clamp was used to measure insulin-stimulated glucose utilization. 13, 14 The euglycaemic clamp procedure was conducted following a 12-h overnight fast, according to methods previously described. 15 Oral glucose tolerance test: A fasting blood sample was obtained, and then a 75 g glucose solution (Glucola, Ames Laboratories, Elkhart, IN, USA) was ingested orally. Blood samples were obtained at 30, 60 and 120 min following ingestion of the glucose load. Each blood sample was immediately centrifuged. Plasma was removed and stored at −80°C until the samples were assayed for glucose and insulin concentration.
Lipids: Fasting blood specimens were sent to the Lipid Research Laboratory of the Hospital of the Medical College of Pennsylvania, where total cholesterol, high-density lipoprotein (HDL) cholesterol and total triglyceride were analysed using standard enzymatic methods and an automated analyser. High-density lipoprotein cholesterol was isolated according to the method of Bachorik et al. 16 Lowdensity lipoprotein (LDL) cholesterol was calculated using the equation for Friedewald et al. 17 Apolipoprotein A 1 , apolipoprotein B and lipoprotein (a) were assayed turbidimetrically using commercial antibodies (Boehringer-Mannheim, Mannheim, Germany).
Euglycaemic hyperinsulinaemic clamp:
During steady-state hyperinsulinaemia, the glucose infusion rate required to maintain euglycaemia quantifies insulin-stimulated glucose metabolism (M, in mg/kg/min). The subject rested for at least 20 min following placement of venous catheters for infusion and sample withdrawal. Euglycaemic hyperinsulinaemia was established with a primed constant infusion of insulin using the method of Rizza et al 14 to compute the priming dose and infusion rate of insulin. The target clamped insulin concentration of 70-80 U/mL of insulin above fasting concentration was achieved with an infusion rate of 40 mU/m 2 /min. Glucose infusion was administered as 20% dextrose. The precise glucose concentration in the 20% dextrose stock solution was measured, and this value was used in the calculation of the glucose infusion rate with the negative feedback equation of Defronzo et al. 13 Euglycaemic hyperinsulinaemia was maintained for 120 min. During the final 60 min of steady-state hyperinsulinaemia, insulin-stimulated glucose utilization (M, in mg/kg/min) was determined from the glucose infusion rate. Using the anthropometric measures, fat-free mass was computed for each subject; insulin-stimulated glucose utilization was also expressed as milligrams per kilograms of fat-free mass per minute (MЈ). Plasma glucose concentration was analysed with the glucose oxidase technique (Glucostat, YSI Model 27, Yellow Springs, OH, USA). Plasma insulin concentration was determined with a solid phase radioimmunoassay (Diagnostic Products Corporation, Los Angeles, CA, USA).
Based upon the results of the sodium-lithium countertransport assay, where the rate of sodiumlithium exchange was defined as V max , the 80 subjects were rank-ordered by V max and divided into tertiles. A two -dimensional directed M-mode echocardiogram was performed on subjects drawn from the highest V max and lowest V max tertiles.
Sodium-lithium countertransport assay: Sodiumlithium countertransport assay was performed on RBCs that were obtained following an overnight fast. Blood for the SLC assay was drawn into heparinized tubes and centrifuged at 2000 g for 4 min at 4°C. The plasma and buffy coat were removed by aspiration and prepared for the SLC assay according to methods previously described, with modifications for kinetic studies of SLC in African Americans. 6 The SLC assay measures the transport of Li + coupled to the Na + gradient as external Na + -stimulated Li + efflux. Previous experiments performed in red cells of hypertensives indicated that Li + efflux was a linear function of external Na + between 0 and 150 mmol/L and did not reach saturation even at 150 mmol/L Na +18 For this reason, a different method was developed to increase external Na + to 260 mmol/L and to avoid cell shrinkage by setting isosmotic conditions. 18 This new procedure was slightly modified for kinetic studies of SLC in African Americans. Efflux was started by addition of 0.7 mL of 50% haematocrit cell suspension to 7 mL of media preincubated at 37°C (final haematocrit 3-4%). Duplicate samples were taken after incubation times of 10, 25, and 40 min, and the media separated by centrifugation at 4°C for 10 min at 6000 g. The Li + concentration of the efflux medium samples was determined by atomic absorption spectrophotometry using standards with the same composition as the flux medium. At every time point, the Li + content of the media (Li m ) in mmol/L of cells (or mol/mL of cells) was determined. Li + efflux into both media was calculated from the slope ± s.e. of the linear regression analysis of Li + content of the media (mmol/L cell) vs time of the six time samples. The V max and K m were calculated from a nonlinear regression analysis of the plot Li + efflux vs external Na + dependence as previously described. 18 Two-dimensional echocardiogram mode measurements were made according to conventions established by the American Society of Echocardiography. 19 An average of three measurements was used to determine end-diastolic interventricular septal wall (IVS) and posterior wall (PW) thickness and left ventricular cavity (LV). Left ventricular wall thickness was measured independently by two trained readers. Inter-observer and intra-observer variation differed by less than 5% and 1%, respectively. Total left ventricular mass (LVM) was derived from the formula described by Devereux et al:
Left ventricular mass index (LVMI) was defined as LVM divided by height in meters. All echocardiograms included a four-chamber view, which were judged to be symmetric. Quality control measures included using one trained technician who was supervised by a trained echocardiographer.
Data analysis
The methods for statistical analysis were as follows. We created SLC subgroups by dividing the entire
Journal of Human Hypertension sample distribution of V max for SLC into tertiles. A one-way ANOVA was used to test for significant differences in mean values in left ventricular structure and other variables between cases stratified to the low V max tertile versus the high V max tertile. Instead of using repeated-measures ANOVA and post hoc ttests for the OGTT data, we compared plasma insulin levels at fasting and used the total sum of insulin to compare the entire curve across all time points. Differences in means and interactions were considered statistically significant at P Ͻ 0.05. Bivariate correlations among numerically continuous variables were examined using Pearson's correlation coefficients.
Results
The sodium-lithium countertransport assay was performed on 80 cases. V max , defined as the rate of sodium-lithium exchange, ranged from 0.06 to 0.67 mmol/L cells/hour. The group of 80 subjects was rank-ordered by V max and then stratified into low, middle and high V max tertiles. Echocardiogram was performed on women from the low V max tertile (range = 0.06 − 0.24 mmol/L cells/hour) and women from the high V max tertile (range = 0.36 − 0.67 mmol/L cells/hour). Two subjects having echocardiograms were excluded from statistical analysis because one echocardiogram was technically inadequate, and another subject developed hypertensive urgency related to cocaine use. Data analysis was conducted on the remaining 35 subjects (low V max tertile n = 22, high V max tertile n = 13).
The mean blood pressure and anthropometric data for the low V max and high V max groups are summarised in Table 1 . There were no differences in weight or BMI between groups, but central body fat was significantly greater in the high V max group. Systolic, diastolic and mean blood pressure were significantly higher in the high V max group compared to the low V max group. The mean value for left ventricular mass index (left ventricular mass divided by height) was significantly greater in the high V max tertile (P = 0.009). Thus highly significantly differences in left ventricular mass index (LVMI) are present in young women with higher V max for SLC prior to clinically significant hypertension. We then examined the relationship of V max for SLC with left ventricular mass and blood pressure as continuous variables. Table 2 provides the results of correlation analyses for V max with anthropometrics, blood pressure and LVMI. Pearson correlation coefficients were statistically significant for V max with systolic blood pressure (P = 0.007), diastolic blood pressure (P = 0.004), mean blood pressure (P = 0.003) and LVMI, (P = 0.02). Figure 1 illustrates the correlation between V max and systolic blood pressure (r = 0.45, P = 0.007) and Figure 2 depicts the correlation of V max with LVMI (r = 0.40, P = 0.02).
We compared metabolic parameters between the low V max and high V max groups. Table 3 provides the mean values in the two groups for fasting lipids, sum of insulin from the OGTT and insulin sensitivity adjusted for fat-free mass (MЈ in mg/kg fat-free mass/min) from the insulin clamp. Compared to the low V max group, HDL cholesterol was significantly lower, and LDL cholesterol was significantly higher in the high V max group (P = 0.01 vs P = 0.04). There were no differences between total cholesterol, triglycerides and apolipoproteins (not shown). Fasting insulin and sum of insulin were significantly greater in the high V max group (P = 0.009 and P = 0.04) compared to the low V max group, whereas insulin sensitivity (MЈ) was greater in the low V max group (P = 0.04).
We also examined the relationships of V max with metabolic parameters as continuous variables. When data were analysed by correlation analysis, there were statistically significant correlations of V max for SLC with fasting insulin, sum of insulin (oral glucose tolerance test) and insulin resistance corrected for fat-free mass (Table 4 ). Figure 3 describes the significant inverse correlation between V max and MЈ (r = −0.55, P = 0.001). There were no significant correlations of V max with lipids in this sample size. Together these data indicate that a higher V max in young African American women is associated with parameters of insulin resistance.
Discussion
Data on this cohort of premenopausal African American women demonstrate a significant direct relationship between V max for SLC and left ventricular mass. These relationships are significant both by categorical and continuous data analysis. There are also significant correlations of V max with blood pressure and measures of insulin resistance which appear to be independent of body size or lipids.
Activity of SLC, measured in RBCs, is considered to be an intermediate phenotype in essential hypertension. Reports from several investigations indicate that this transporter could be a genetic marker for essential hypertension. 21, 22 However, the genotype has not been identified, 23 and alterations in SLC are not related to genes encoding the sodium-hydrogen antiporter (Na/H Exc) isoform 1. 24 V max was recently shown to positively predict the development of hypertension in males with high normal blood pressure. Strazzullo et al 25 reported the results of an 8-year blood pressure outcome study in which men with blood pressure in the high baseline blood pressure tertile, as well as high V max tertile, had a greater rate of progression to hypertension. Progression to hypertension at 8 years did not occur in cases with low V max despite higher baseline blood Journal of Human Hypertension pressures, indicating a negative predictive value with cases having a low V max .
Epidemiologic studies have documented that high levels of SLC activity are more common in patients with essential hypertension who have concurrent metabolic abnormalities, such as elevated plasma triglycerides, increased BMI, elevated uric acid levels, and impaired glucose tolerance. [26] [27] [28] All of these metabolic abnormalities have been associated with insulin resistance and hyperinsulinaemia. 29, 30 In a previous investigation in young adult African Americans, we examined both SLC activity and Na/H Exc activity in RBCs. 5 In that sample, increased activity of both transporters was present in those cases having both hypertension and insulin resistance. However, elevation of V max for SLC was present in cases with insulin resistance whether normotensive or hypertensive. Thus, among young adult African Americans, a higher V max for SLC was strongly related to metabolic parameters and preceded hypertension.
Left ventricular hypertrophy has been shown to be an independent risk factor for cardiovascular disease. 10, 31, 32 In Caucasian men and women, there is an association of increased V max for SLC with the presence of left ventricular hypertrophy 33, 34 Nosadini et al 7 reported elevated SLC activity in a subset of hypertensive patients who had left ventricular hypertrophy, elevated glomerular filtration rates, larger kidney volume, and high urinary albumin excretion, compared to hypertensive patients with normal SLC activity who did not have cardiac or renal abnormalities. Other reports now support an association of elevated SLC activity with renal and cardiac sequelae of essential hypertension and also with diabetes. [33] [34] [35] [36] [37] For example, Sampson et al, 38 in a study of diabetic Caucasian males, reported that increased SLC activity was associated with greater left ventricular mass in diabetics both with and without hypertension. In view of the high rates of diabetes and diabetic nephropathy, as well as high rates of cardiovascular disease in African Amer- Figure 3 Correlation of V max with MЈ (insulin sensitivity adjusted for fat-free mass). The scatter plot provides the value for V max for SLC and clamp-determined measure of insulin sensitivity (MЈ) which is corrected for adipose mass and expressed as insulin-stimulated glucose uptake in mg/kg fat-free mass min. There is a statistically significant inverse correlation of V max for SLC with MЈ (r = −0.55, P = 0.001).
icans, the observations in our study suggest that the V max for SLC could act as a marker of high risk for vascular injury.
The findings of this study demonstrate a significant direct relationship of V max for SLC with both LVMI and blood pressure in African American women. The relationship of blood pressure with risk for organ injury and vascular events is known to be continuous and evidence of injury may be present at blood pressure levels in the high normal range. However, in these young women, evidence of left ventricular hypertrophy is present at a young age and with mild blood pressure elevation. The elevated V max for SLC is a consistent marker for these cases. The data also confirm the relationship of V max for SLC with the metabolic parameters of insulin resistance, which confirm in African Americans previous reports on Caucasian populations. V max may be useful as a predictor of both future hypertension and increased LVMI in women with normal and high normal blood pressure, independent of body size. Alterations in activity of this sodium transporter may identify a subgroup of hypertensive African American women at risk for cardiovascular disease, and provide an opportunity for early intervention.
